Gabelli Funds’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Gabelli Funds’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-578,517	Closed	-$11M	–	1219
2019 Q1	$11M	Sell	578,517 -15,155	-3%	-$246K	0.07%	344
2018 Q4	$8.02M	Buy	593,672 +133,283	+29%	+$1.49M	0.06%	389
2018 Q3	$5.11M	Buy	+460,389	New	+$4.61M	0.03%	562

Other funds holding OSIR

FGAM

Financial Gravity Asset Management Lakeway, Texas $562M AUM

Gabelli Funds's OSIR Position: Q2 2019 in Review

Gabelli Funds sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 578,517 shares — an estimated $11M sold.

Gabelli Funds first reported a position in OSIR in Q3 2018 and held it in 3 quarters. The position peaked at $11M in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

Gabelli Funds reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Gabelli Funds sold 578,517 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $11M.
Gabelli Funds first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2018 and held it in 3 quarters.
Gabelli Funds's Osiris Therapeutics, Inc. Common Stock position peaked at $11M in Q1 2019.
1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Gabelli Funds's 13F filing for Q2 2019, filed 2 Aug 2019.